Biocides

Biocides

Biocidal Products Regulation: focus on ozone

The Biocidal Products Regulation (EU) 528/2012 aims to enhance human and environmental protection, streamline active substance evaluations, and simplify biocidal product authorizations. It outlines the classification of biocidal products and the approval process for active substances like ozone.
Biocides

United States: which exemptions to commercialise hand sanitizers and disinfectants?

Learn about the temporary guidance in the US for commercializing hand sanitizers during the pandemic. Understand the requirements and formulation needed to produce hand rubs. Discover the strict rules for placing hard surface disinfectants on the American market.
Biocides

Leave-on hydroalcoholic hand gels marketed as cosmetics?

The European Commission released an addendum clarifying banned claims in cosmetics for hand gels. The document provides a negative list of prohibited claims and images. Understanding the difference between cosmetic and biocidal products is crucial for marketing strategies. Consider the advantages of marketing a leave-on cleansing gel versus a hand disinfectant.
Biocides

New concentration limit for non-active endocrine disruptors

The EU has set a new concentration limit of 0.1% for non-active substances identified as endocrine disruptors in biocidal products. This limit applies even if multiple substances are present. Regulations aim to control risks and progressively eliminate these disruptors.
Biocides

Hand sanitizers and disinfectants: placing them on the EU market and ensuring their compliance during and after the pandemic

Explore the accelerated and simplified processes for placing disinfectants and sanitizers on the market during the Covid-19 pandemic. Learn about exemptions, compliance requirements, and the role of active substances in ensuring these essential products meet regulatory standards.
Biocides

GB BPR: resubmission of dossiers before 29th June

Post-Brexit, the UK established its own biocides regulation, requiring companies to resubmit marketing authorisation and active substance approval dossiers to the Health & Safety Executive. This process involves new forms and data submissions to ensure compliance with the GB BPR.